This preview shows page 1-2-3-22-23-24-44-45-46 out of 46 pages.

Save
View full document
View full document
Premium Document
Do you want full access? Go Premium and unlock all 46 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 46 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 46 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 46 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 46 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 46 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 46 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 46 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 46 pages.
Access to all documents
Download any document
Ad free experience
Premium Document
Do you want full access? Go Premium and unlock all 46 pages.
Access to all documents
Download any document
Ad free experience

Unformatted text preview:

Slide 1Alzheimer's DiaseaseCholinesterase inhibitors for ADSeizuresDrug treatmentSlide 6DilantinSlide 8TegretolSlide 11DepakoteDepakoteEthosuximide (Zarontin)Phenobarbital (Luminal)Newer agentsStatus EpilepticusDepressionClassification of antidepressnats:Tricyclic antidepressantsSelective Serotonin Reuptake Inhibitors (SSRI’s)Serotonin/norepinephrine reuptake InhibitorsMonoamine Oxidase Inhibitors (MAOI’s)MAOI’sBupropion (Wellbutrin)Serotonin syndromeLiver FunctionBipolar DisorderLithiumLithiumPsychosisClassification of antipsychoticsConventional antipsychoticsDepot preparation of antipsychoticsAtypical antipsychoticsExample of atypical antipsychoticsAnxietyDrugs for sleepBenzodiazepinesBenzosBenzo-likeBarbituatesAntihistamines for insomniaTobaccoAlcoholADHDNSG 3259/16NeurologyPsychiatryWhat is it? Neuronal degeneration of hippocampus (involves memory) and cerebral cortex (speech, perception, reasoning, motor function…)◦Associated with low levels of acetylcholineSymptoms: progressive dementia, typically begins > 65 yearsCause: unknown Diagnosis: no specific testTreatment: cholinesterase inhibitors that work inBrain(To help with this, review parasympathetic, muscarinic,acetylcholine)Alzheimer's DiaseaseThe drugs:◦Donepezil (Aricept®)- reversibly inhibit cholinesterase◦Rivastigmine (Exelon®)-irreversibly inhibit cholinesteraseMechanism of action: prevent breakdown of acetylcholine by acetylcholinesterase in the brain  increases availability of acetylcholine. Reversible.◦Not a cure. May slow progression, not stop it.ADR’s:◦Cholinergic effects : nausea, vomiting, diarrhea, dizziness headache, bronchoconstrictionDrug interactions: anticholinergicsCholinesterase inhibitors for ADEpilepsy: a group of disorders characterized by excessive excitability of neurons in CNS.Causes: congenital defects in brain, hypoxia at birth, head trauma, brain tumors, hypoglycemiaClassification:◦Partial: Simple or complex◦Generalized:Tonic-clonic, absence; febrile, othersSeizuresTherapeutic goals:◦Reduce seizure frequency to an extent that enables patient to live as normal a life as possible◦Avoid side effects as much as possibleDrug selection:◦Most drugs work only for certain types of seizures◦Accurate diagnosis of seizure type essentialDrug levels are often obtained for antiepileptic drugs:◦Used as a guide to adjust dosage so that levels are within therapeutic range◦A way to monitor complianceDrug treatmentTraditional (Older) antiepileptics:◦Phenytoin (Dilantin®)/Fosphenytoin (Cerebrex)◦Carbamazepine (Tegretol®)◦Valproic acid (Depakene®, Depakote®)◦Ethosuximide (Zarontin®)◦Phenobarbital (Luminal®)◦OthersMechanism of action: suppresses activity of seizure-generating neurons by blocking Na channels of neuronsPharmacokinetic considerations:◦Absorption and metabolism vary widely among patientsDosages must be individualized◦Very narrow therapeutic range (10-20 )Appropriate drug levels difficult to achievePatients must adhere strictly to regimenDilantinMain uses:◦All major types of seizures except absence◦Drug of choice for tonic-clonic in adults and older children◦Cardiac dysrhythmiasADR’s at therapeutic doses:◦Gingival hyperplasia (20%)◦Skin rash (2-5%)◦IV injection-hypotension; arrhythmiasPregnancy: Category Dimportant ADR’s at toxic doses:◦Nystagmus- may also occur at therapeutic doses◦Sedation◦Ataxia◦Diplopia◦Cognitive impairmentImportant drug interactions:◦Decreases effectiveness of warfarin◦CNS depressants- increases sedationWithdrawal: Slowly. If rapid  status epilepticusPhenytoin:Dilute in saline. Infusion rate NMT 50 mg/min. Filter needleFosphenytoin more soluble; may use dextrose; give IV or IMMechanism of action: same as Dilantin®Therapeutic uses:◦Partial seizures- drug of first choice◦Tonic-clonic seizures◦Bipolar disorderADR’s:◦Many neurologic symptoms, but not associated with cognitive impairment (like Dilantin®)◦Bone marrow suppression (CBC’s should be monitored regularly)TegretolPregnancy: Category DImportant drug interactions:◦Decreases effectiveness of warfarinImportant food interaction:◦Grapefruit juice- increases toxicity of carbamazepineMechanisms of action: (3)◦Same as Tegretol® and Dilantin®◦Also suppresses calcium channels◦Also enhances GABATherapeutic uses:◦A first-line drug for all seizure types, including absence.◦Bipolar disorder◦Migraine headachesDepakoteMost common ADR:◦GI effectsMost serious ADR:◦Liver toxicity- rare, but can be fatalMore common at higher doses, children less than 2 on multidrug therapyPregnancy: Category DDepakoteMechanism of action: inhibits calcium currents in the thalamusTherapeutic use: ◦Drug of first choice for absence seizures◦Not effective for other seizure typesADR’s:◦Generally well-tolerated◦Rare, but serious reactions include lupus-like syndrome, aplastic anemia, and leukopenia Ethosuximide (Zarontin)Mechanism: enhances effects of GABA◦Member of barbiturate family◦One of oldest antiseizure drugsUses: ◦tonic-clonic and partial seizures, not absence seizures◦insomniaADR’s: lethargy most common. Physical dependence a risk. Also sedation, depressionToxicity: respiratory depression and death if overdoseWithdrawal: slowly to prevent SEPhenobarbital (Luminal)Gabapentin (Neurontin) ◦Analogue of GABA; enhances GABA release ◦Well tolerated; common side effects are somnolence◦Eliminated by the kidneysLevetiracetam (Keppra)◦approved for adjunctive therapy for partial seizures in adults◦common effects are drowsiness and asthenia Topiramate (Topamax) is approved as adjunct for partial seizures in adults; migraines, weight loss; may cause metabolic acidosis-monitor bicarbonateNewer agentsDefinition of generalized SE: continuous tonic-clonic seizures that last > 20-30min.◦Associated with increased HR, BP, temperature◦Hypoglycemia and acidosis can occur◦Permanent neurologic injury/death can occurInitial therapy to end seizures quickly:◦Benzodiazepines (IV)Lorazepam (Ativan®) or diazepam (Valium®)Follow-up therapy to suppress seizures:◦Phenytoin (Dilantin®)Status EpilepticusMost common psychiatric illness◦Underdiagnosed, undertreatedPrincipal symptoms: depressed mood, loss of pleasure or interest in usual


View Full Document

UNCW NSG 325 - NSG 325 Module 3

Download NSG 325 Module 3
Our administrator received your request to download this document. We will send you the file to your email shortly.
Loading Unlocking...
Login

Join to view NSG 325 Module 3 and access 3M+ class-specific study document.

or
We will never post anything without your permission.
Don't have an account?
Sign Up

Join to view NSG 325 Module 3 2 2 and access 3M+ class-specific study document.

or

By creating an account you agree to our Privacy Policy and Terms Of Use

Already a member?